Buparlisib
CAS: 944396-07-0
Ref. TM-T1827
| 5mg | 62.00 € | ||
| 10mg | 83.00 € | ||
| 25mg | 92.00 € | ||
| 50mg | 113.00 € | ||
| 100mg | 142.00 € | ||
| 200mg | 231.00 € | ||
| 500mg | 417.00 € | ||
| 1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Thursday 16 Jan 2025
Product Information
Name:
Buparlisib
Synonyms:
- NVP-BKM120
- BKM120
- 2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-
- 5-(2,6-Dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridine-2-amine
- Bkm 120
- Bkm 120Nx
- Bkm120
- Nvp-Bkm 120
- Nvp-Bkm120
Description:
Buparlisib (BKM120) is an orally bioavailable specific oral inhibitor of the pan-class I PI3K (IC50s: 52/166/116/nM for p110α, p110β, and p110δ).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
410.39
Formula:
C18H21F3N6O2
Purity:
95.32% - 98.4%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1827 Buparlisib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
